Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-07
2006-03-07
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254110, C514S320000, C514S449000, C544S147000, C544S374000, C546S196000, C549S510000, C549S511000
Reexamination Certificate
active
07008942
ABSTRACT:
A cytotoxic agent comprising one or more taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more taxanes covalently bonded to a cell binding agent through a linking group, and (B) a pharmaceutically acceptable carrier, diluent or excipient. A method for killing selected cell populations comprising contacting target cells or tissue containing target cells with an effective amount of a cytotoxic agent comprising one or more taxanes linked to a cell binding agent. Novel sulfur-containing taxanes.
REFERENCES:
patent: 5399726 (1995-03-01), Holton
patent: 5416064 (1995-05-01), Chari
patent: 5475011 (1995-12-01), Ojima
patent: 5475092 (1995-12-01), Chari
patent: 5811452 (1998-09-01), Ojima
patent: 5824701 (1998-10-01), Greenwald
patent: 6175023 (2001-01-01), Liu
patent: 6340701 (2002-01-01), Chari et al.
patent: 0624377 (1994-05-01), None
patent: 1033372 (2000-09-01), None
patent: WO 89/12624 (1989-12-01), None
patent: WO 97/44026 (1997-11-01), None
patent: WO 98/19705 (1998-05-01), None
patent: WO 98/52614 (1998-11-01), None
patent: WO 00/50059 (2000-08-01), None
Huff, Journal of Medicinal Chemistry, vol. 34, No. 8, pp. 2305-2314, (1991).
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Safavy et al,J. Med. Chem., 42:4919-4924 (1999).
American Chemical Society Division of Medicinal Chemistry, Abstracts, 218thACS National Meeting, New Orleans, LA, Aug. 22-26, 1999, A. Trainor, Program Chair.
Synthesis and Biological Activity of Advanced 2nd-Generation Taxoids, Tao Wang et al, Dept. of Chem., State Univ. of NY at Stony Brook, NY 11794-3400; Dept. of Exp. Therapeutics, Roswell Park Cancer Inst., Elm and Carlton Streets, Buffalo, NY 14263, pp. 1-12.
Ojima et al,J. Med. Chem., 40:267-278 (1997).
Ojima et al,Proc. Natl. Acad. Sci., USA, 96:4256-4261 (1999).
Michael L. Miller, et al. “Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies”,Bioorganic&Medicinal Chemistry Letters14 (2004) 4079-4082.
Erkan Baloglu et al. “Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors”,Bioorganic&Medicinal Chemistry Letters14 (2004) 5885-5888.
Michael L. Miller, et al. “Synthesis of Taxoids with Improved Cytotoxicity and Solubility for Use in Tumor-Specific Delivery”,J. Med. Chem., 2004, 47, 4802-4805.
Blättler Walter A.
Chari Ravi V. J.
Anderson Rebecca
Immunogen Inc.
Saeed Kamal A.
LandOfFree
Cytotoxic agents comprising taxanes and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic agents comprising taxanes and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic agents comprising taxanes and their therapeutic use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3577568